======= SOCS7 ======= == Gene Information == * **Official Symbol**: SOCS7 * **Official Name**: suppressor of cytokine signaling 7 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=30837|30837]] * **UniProt**: [[https://www.uniprot.org/uniprot/O14512|O14512]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SOCS7&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SOCS7|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608788|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Regulates signaling cascades probably through protein ubiquitination and/or sequestration. Functions in insulin signaling and glucose homeostasis through IRS1 ubiquitination and subsequent proteasomal degradation. Inhibits also prolactin, growth hormone and leptin signaling by preventing STAT3 and STAT5 activation, sequestering them in the cytoplasm and reducing their binding to DNA. May be a substrate recognition component of a SCF- like E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (By similarity). {ECO:0000250, ECO:0000269|PubMed:15677474, ECO:0000269|PubMed:16127460}. |SOCS box| |SH2| |1-phosphatidylinositol-3-kinase regulator activity| |phosphatidylinositol 3-kinase complex| |phosphatidylinositol phosphorylation| |regulation of phosphatidylinositol 3-kinase activity| |regulation of lipid kinase activity| |lipid phosphorylation| |regulation of phospholipid metabolic process| |SH3 domain binding| |phosphatidylinositol metabolic process| |lipid modification| |glycerophospholipid metabolic process| |phospholipid metabolic process| |glycerolipid metabolic process| |regulation of lipid metabolic process| |regulation of growth| |protein ubiquitination| |protein modification by small protein conjugation| |regulation of kinase activity| |organophosphate metabolic process| |cellular lipid metabolic process| |regulation of transferase activity| |protein modification by small protein conjugation or removal| |lipid metabolic process| |negative regulation of signal transduction| |phosphorylation| |negative regulation of cell communication| |negative regulation of signaling| |regulation of phosphorylation| |negative regulation of response to stimulus| |intracellular signal transduction| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp180|Dynasore 10μM R04 exp180]]|-1.76| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|1.75| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|1.78| |[[:results:exp49|NFN1 0.1μM R01 exp49]]|1.83| |[[:results:exp218|A-395 10μM R05 exp218]]|2| |[[:results:exp61|YM155 0.0002μM R01 exp61]]|2.01| |[[:results:exp52|Ribavirin 10μM R01 exp52]]|2.03| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|2.06| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10068 * **Expression level (log2 read counts)**: 5.68 {{:chemogenomics:nalm6 dist.png?nolink |}}